SSRI Antidepressant Medications: Adverse Effects and Tolerability
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Side effects of antidepressants can be predicted by receptor selectivity and site of action. Although the selective serotonin reuptake inhibitors (SSRIs) have better overall safety and tolerability than older antidepressants, broad-based experience with SSRIs has shown the frequency and type of side effects to be increased relative to clinical trial data. The author explores the reasons for the different profiles and discusses adverse effects, especially sexual dysfunction, weight gain, and sleep disturbance, the most troubling adverse events seen during long-term SSRI therapy. The informed management of these side effects by primary care practitioners supports successful treatment of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been routinely identified to cause less severe withdrawal effects than other SSRIs, which has been attributed to its longer half-life 3,30,75 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However many of these drugs can acutely induce adverse side effects including anxiety and increased risk of suicidal behaviors (Ferguson, 2001; Gartlehner et al., 2011; Vaswani et al., 2003).”
From Molecular and anatomical organization of the dorsal raphe nucleus (2019) · cites this paper as Ferguson, 2001
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During long-term use of SSRIs, the most troubling adverse effects seem to be gastrointestinal problems, sleep disturbances and sexual dysfunction,49”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [49]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“often intolerable side-effects”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [260]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“many patients refusing to take traditional antidepressants due to their side-effects”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [260]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arky, R. A. (1994) · Cited by 2,632
The Arizona Sexual Experience Scale (ASEX): Reliability and Validity
A. McGahuey, A. J. G. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278623 · Cited by 1,155
Effects of SSRIs on Sexual Function: A Critical Review
Rosen, R. C., Lane, R. M., & Menza, M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00013 · Cited by 650
1995 Physicians' Desk Reference
Schild, S. M. (1995) · AORN Journal · doi:10.1016/s0001-2092(06)63819-2 · Cited by 497
Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors
Edwards, J. G., & Anderson, I. (1999) · Drugs · doi:10.2165/00003495-199957040-00005 · Cited by 458
Mechanism of action of antidepressant medications.
Feighner, J. P. (1999) · PubMed · Cited by 323
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+<1::aid-da1>3.3.co;2-j · Cited by 278
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+<11::aid-da4>3.0.co;2-i · Cited by 266
Spigset, O. (1999) · Drug Safety · doi:10.2165/00002018-199920030-00007 · Cited by 225
Anorgasmia from Clomipramine in Obsessive-Compulsive Disorder: A Controlled Trial
Monteiro, W. O., Noshirvani, H. F., Marks, I. M., & Lelliott, P. T. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.151.1.107 · Cited by 201
Cited by
Items 301–400 of 670
Lax, N. C., Parker, S. J., Hilton, E., Seliman, Y., Tidgewell, K. J., & Kolber, B. J. (2018) · Synapse · doi:10.1002/syn.22059 · Cited by 19
Hao, Y., Hu, Y., Wang, H., Paudel, D., Xu, Y., & Zhang, B. (2019) · Nature and Science of Sleep · doi:10.2147/nss.s220947 · Cited by 18
“Although TCAs are effective antidepressants, their effects on receptor systems like histaminic, cholinergic, and adrenergic systems, might cause some intolerable adverse effects which limit their clinical usage.(15) More recently, as a safer treatment alternative, selective serotonin reuptake inhibitors (SSRIs) have b…”
BackgroundInvolvement of muscarinic receptor mechanisms in antidepressant drug action
Witkin, J. M., Smith, J. L., Golani, L. K., Brooks, E. A., & Martin, A. E. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.03.003 · Cited by 18
Pereira, G., Gillies, H., Chanda, S., Corbett, M., Vernon, S. D., Milani, T., & Bateman, L. (2021) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2021.698240 · Cited by 18
“…the selective serotonin Frontiers in Systems Neuroscience | www.frontiersin.org 2 September 2021 | Volume 15 | Article 698240 FIGURE 1 | Etiological hypothesis. reuptake inhibitors (SSRIs) indiscriminately modulate 5HT, so can cause fever, chills, blurry vision, tinnitus, etc. (Ferguson, 2001).”
BackgroundManaging Mental Health Conditions in Primary Care Settings
Hackley, B. K., Sharma, C., Kedzior, A., & Sreenivasan, S. (2009) · Journal of Midwifery & Women s Health · doi:10.1016/j.jmwh.2009.06.004 · Cited by 17
“Women who have difficulty adhering to an oral medication regimen and are therefore more likely to miss doses should not be prescribed a SSRI with a short half-life.(41) Antidepressants with short half-lives are more likely to trigger withdrawal symptoms if they are abruptly discontinued.”
BackgroundWald, R., Dodman, N. H., & Shuster, L. (2009) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0016402 · Cited by 17
Perspectives in Designing Multifunctional Molecules in Antipsychotic Drug Discovery
Milelli, A., Turrini, E., Catanzaro, E., Maffei, F., & Fimognari, C. (2016) · Drug Development Research · doi:10.1002/ddr.21334 · Cited by 17
Shergis, J. L., Hyde, A. J., Meaklim, H., Varma, P., Costa, C. D., & Jackson, M. L. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102657 · Cited by 18
Silexan in anxiety, depression, and related disorders: pharmacological background and clinical data
Kasper, S. F., & Eckert, A. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01923-8 · Cited by 19
“…side effects such as fatigue, sedation, somnolence, which have been described even for newer-generation chemical anti-depressants and anxiolytics [21, 88], may further diminish the patients’ already impaired functional level and may, for example, increase the risk of falls and cognitive impairment.”
Pakfetrat, A., Talebi, M., Dalirsani, Z., Mohajeri, S. A., Zamani, R., & Ghazi, A. (2019) · PubMed Central · doi:10.22038/ajp.2019.12764 · Cited by 20
“Citalopram as a selective serotonin reuptake inhibitor, has fewer side effects in comparison with other drugs of this group, and its efficacy in treating BMS was shown in previous studies (Ebrahimi et al., 2009; Ferguson, 2001; Miller et al., 2004).”
ResultMolecular basis for the association between depression and circadian rhythm
Liu, I. Y., & Varinthra, P. (2019) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_181_18 · Cited by 21
“Paroxetine Fluvoxamine SSRIs Selectively inhibit reuptake of serotonin Insomnia treatment: Paroxetine (20 mg), fluvoxamine (50 mg) Sexual functioning, sleepiness, weight gain, agitation, dizziness, dry mouth, nausea, nervousness, headache, vomiting, diarrhea [37-40]”
BackgroundAguilar‐Martínez, I. S., Reyes‐Méndez, M. E., Herrera-Zamora, J. M., Osuna‐López, F., Virgen‐Ortiz, A., Mendoza‐Muñoz, N., Góngora-Alfaro, J. L., Moreno-Galindo, E. G., & Alamilla, J. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05528-6 · Cited by 15
“Anxiety is a common unwanted side effect produced by SSRIs, such as Cit (Ferguson 2001; Kelly et al. 2008; Jakobsen et al. 2017).”
BackgroundInfluentialFirouzabadi, D., Kheshti, F., Abdollahifard, S., Taherifard, E., & Kheshti, M. R. (2022) · Health Science Reports · doi:10.1002/hsr2.892 · Cited by 13
“like all other medications, their adverse effects are variable between different populations and are mostly transient and leave no sequala for the patients in particular when used for a short duration of time.(58)”
BackgroundMetabolism of Glycogen in Brain White Matter
Brown, A. M., Rich, L. R., & Ransom, B. R. (2019) · Advances in neurobiology · doi:10.1007/978-3-030-27480-1_7 · Cited by 17
Kanapathy, J., & Bogle, V. (2019) · Journal of Health Psychology · doi:10.1177/1359105317713360 · Cited by 14
Ivashchenko, A. A., Ma, M., Vostokova, N., Герович, Б. А., Bukhanovskaya, O. A., Burminskiy, D. S., Egorova, A. N., Gluskina, L. Y., Gorchakov, D. S., Karapetian, R. N., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.10.008 · Cited by 14
Cope, Z. A., Murai, T., & Rizzo, S. J. S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.805063 · Cited by 18
“Modern SSRIs seek to minimize their anticholinergic properties, which are associated with the most poorly tolerated side effects of modern anti-depressants, such as sedation, dry mouth, constipation, loss of libido and sexual dysfunction (Ferguson, 2001).”
BackgroundGülpen, J., Breedvelt, J., van Dis, E. A. M., Geurtsen, G. J., Warren, F. C., Heeringen, C. V., Hitchcock, C., Holländare, F., Huijbers, M. J., Jarrett, R. B., et al. (2025) · Psychological Medicine · doi:10.1017/s0033291725000157 · Cited by 18
“Moreover, patients prefer psychological treatment (McHugh et al., 2013), experience side effects from ADM (Anderson et al., 2012; Ferguson, 2001), and can resist prophylactic properties with long-term usage (Kaymaz et al., 2008), underscoring the limitations of relying solely on ADM.”
An Updated List of Neuromedicinal Plants of Pakistan, Their Uses, and Phytochemistry
Khan, A. W., Khan, A., Shah, S. M. M., Ullah, A., Faheem, M., & Saleem, M. H. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/6191505 · Cited by 18
Firoozeei, T. S., Barekatain, M., Karimi, M., Zargaran, A., Akhondzadeh, S., & Rezaeizadeh, H. (2020) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2020.06.002 · Cited by 19
Identifying and Managing Anxiety Disorders in Primary Care
Brahmbhatt, A., Richardson, L. G., & Prajapati, S. (2020) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2020.10.019 · Cited by 18
Guimarães, C. F., Pereira, L. R. L., Iucif, N., Cesarino, E. J., Nogueira‐de‐Almeida, C. A., de Carvalho, D., & Queiróz, R. H. C. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000600007 · Cited by 18
“, after breakfast, to avoid side effects like nausea and vomiting (28).”
BackgroundLee, S. H., Mastronardi, C. A., Li, R. W., Paz-Filho, G., Dutcher, E. G., Lewis, M. D., Vincent, A. D., Smith, P. N., Bornstein, S. R., Licinio, J., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-018-0351-z · Cited by 12
Shallcross, A. J., Duberstein, Z. T., Sperber, S. H., Visvanathan, P. D., Lutfeali, S., Lu, N. Y., Carmody, J., & Spruill, T. M. (2021) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2020.12.004 · Cited by 14
Cosmetic presentations and challenges of body dysmorphic disorder and its collaborative management
Shivakumar, S., Jafferany, M., Sood, S., & Sushruth, V. (2021) · Journal of Cutaneous and Aesthetic Surgery · doi:10.4103/jcas.jcas_180_20 · Cited by 16
“SSRIs are second-generation anti-depressant drugs.[48] Fluvoxamine, fluoxetine, citalopram, and escitalopram are the most common drugs from this class used for BDD.”
BackgroundInfluentialReview of Psychotropic Agents Associated with Sialorrhoea, Except Clozapine
Halder, A., Ravindran, N. P., Nagda, P., Harshe, D. G., & Harshe, G. (2021) · Indian Journal of Psychological Medicine · doi:10.1177/02537176211025789 · Cited by 13
Ahmadimanesh, M., Etemad, L., Rad, D. M., Ghahremani, M. H., Mohammadpour, A. H., Esfehani, R. J., Jowsey, P. A., Behdani, F., Moallem, S. A., & Abbaszadegan, M. R. (2023) · PubMed Central · doi:10.22038/ijbms.2023.66496.14595 · Cited by 18
“The present research focused on two well-known antidepressant agents, including citalopram and sertraline from the SSRI category that act selectively on serotonin receptors (52).”
Anxiolytic-like effects of alverine citrate in experimental mouse models of anxiety.
Gupta, D., Radhakrishnan, M., & Kurhe, Y. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.08.033 · Cited by 12
Wentink, C., Huijbers, M. J., Lucassen, P. L., Kramers, C., Akkermans, R., Adang, E., Spijker, J., & Speckens, A. E. M. (2019) · BMC Family Practice · doi:10.1186/s12875-019-0989-5 · Cited by 15
Cannabinoids as an Emerging Therapy for Posttraumatic Stress Disorder and Substance Use Disorders
Cohen, J., Wei, Z., Phang, J., Laprairie, R. B., & Zhang, Y. (2019) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0000000000000612 · Cited by 13
Ayyash, A., & Holloway, A. C. (2021) · Journal of Applied Toxicology · doi:10.1002/jat.4272 · Cited by 14
“Long-term SSRI use is associated with increased weight gain, dyslipidemia, and new-onset type 2 diabetes (Ferguson, 2001; Jerrell, 2010; Raeder et al., 2006; Sussman & Ginsberg, 1998; Yoon et al., 2013).”
Kuburi, S., Passa, A.-M. D., Tassone, V. K., Mahmood, R., Lalovic, A., Ladha, K. S., Dunlop, K., Rizvi, S. J., Demchenko, I., & Bhat, V. (2022) · Chronic Stress · doi:10.1177/24705470221115342 · Cited by 18
Cutler, A. J., Mattingly, G. W., Kornstein, S. G., Aaronson, S. T., Lasser, R. A., Zhang, H., Rana, N., Brown, C., Levin, S. N., Miller, C., et al. (2023) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.23m14845 · Cited by 15
Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
Yu, S., Zhang, X., Wu, L., Wan, D., Liu, R., Dong, Z., & Chen, M. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s87968 · Cited by 17
Bhattacharjee, S., Lee, J. K., Patanwala, A. E., Vadiei, N., Malone, D. C., Knapp, S. M., Lo-Ciganic, W.-H., & Burke, W. J. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.02.002 · Cited by 15
In vitro inhibitory activity of sertraline against clinical isolates of Sporothrix schenckii
Villanueva‐Lozano, H., Treviño‐Rangel, R. D. J., Téllez-Marroquín, R., Bonifáz, A., Rojas, O. C., Hernández-Rodríguez, P. A., & González, G. M. (2019) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2019.01.004 · Cited by 13
Study of Adherence Pattern of Antidepressants in Patients with Depression.
Manandhar, J. S., Shrestha, R., Basnet, N., Silwal, P., Shrestha, H., Risal, A., & Kunwar, D. (2017) · PubMed · Cited by 18
Coulombe, J., Moodie, E. E. M., Shortreed, S. M., & Renoux, C. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa260 · Cited by 16
Impact of duloxetine on male fertility: A randomised controlled clinical trial
Punjani, N., Kang, C. L., Flannigan, R. K., Bach, P. V., Altemus, M. M., Kocsis, J. H., Wu, A. H. B., Pierce, H., & Schlegel, P. N. (2021) · Andrologia · doi:10.1111/and.14207 · Cited by 14
“One commonly prescribed class is the serotonin and norepinephrine reuptake inhibitors (SNRIs), which include venlafaxine and duloxetine (Cascade et al., 2007; Ferguson, 2001).”
BackgroundThe Potential Role of Serotonergic Hallucinogens in Depression Treatment
Psiuk, D., Nowak, E., Cholewa, K., Łopuszańska, U., & Samardakiewicz, M. (2021) · Life · doi:10.3390/life11080765 · Cited by 16
“Moreover, if administered in properly prepared and safe conditions, serotonergic hallucinogens demonstrate only mild and temporary adverse events, such as transient anxiety, headache, dizziness, and nausea (Table 3), whereas antidepressants drugs are associated with a wide range of persistent adverse events, such as w…”
BackgroundGinseng Berry and its Biological Effects as a Natural Phytochemical
Kim, J., & Cho, S. Y. (2016) · Natural Products Chemistry & Research · doi:10.4172/2329-6836.1000209 · Cited by 12
Schedule 1 barriers to research in the UK: An in-depth qualitative analysis
Howard, A., Neill, J. C., Schlag, A. K., & Lennox, C. (2021) · Drug Science Policy and Law · doi:10.1177/20503245211049313 · Cited by 15
Strategies for drug repurposing against coronavirus targets
Smith, P. O., Jin, P., & Rahman, K. M. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100072 · Cited by 14
“typically displaying low therapeutic indices, resulting in their micromolar range in vitro efficacies translating to significantly higher doses than therapeutically accepted (Ferguson, 2001; Khushboo and Sharma, 2017).”
Jog, M., Norris, V., Pfeiffer, P., Taraku, B., Kozikowski, S. D., Schneider, J., Boucher, M., Iacoboni, M., Woods, R., & Narr, K. L. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.31189 · Cited by 16
Role and rationale for the use of milnacipran in the management of fibromyalgia
Gendreau, M. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s9622 · Cited by 13
Pycnogenol supplementation as an adjunct treatment for antidepressant-induced sexual dysfunction
Smetanka, A., Stara, V., Farský, I., Tonhajzerová, I., & Ondrejka, I. (2019) · Physiology International · doi:10.1556/2060.106.2019.02 · Cited by 13
Chauhan, T., Rani, V., Sahu, B., Sharma, A., Kheruka, S. C., Gambhir, S., Dube, V., Aggarwal, L. M., & Chawla, R. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101780 · Cited by 13
Adjei, K., Adunlin, G., & Ali, A. A. (2023) · Healthcare · doi:10.3390/healthcare11050740 · Cited by 19
Wang, L. R., Kim, S., & Baek, S. (2019) · Journal of Exercise Rehabilitation · doi:10.12965/jer.1938094.047 · Cited by 13
“Fluoxetine is the most widely used antidepressant acting as one of the serotonin reuptake inhibitors (SSRIs) (Ferguson, 2001).”
BackgroundPerić, I., Costina, V., Djordjević, S., Gass, P., Findeisen, P., Inta, D., Borgwardt, S., & Filipović, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-97186-7 · Cited by 15
Taylor, G. V., Shallenberger, J. R., Tint, S., Fones, A., Hamilton, H., Yu, L., Amini, S., & Hettinger, J. D. (2021) · Surface and Coatings Technology · doi:10.1016/j.surfcoat.2021.127803 · Cited by 12
Filho, L. A. M. D. S. D., Amariz, I. A. E., Nishimura, R. H. V., Massaranduba, A. B. R., Menezes, P. M. N., Damasceno, T. A., Brys, I., Rolim, L. A., Silva, F. S., & Ribeiro, L. A. D. A. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221104050 · Cited by 17
“Nevertheless, the most diverse side effects (Ferguson, 2001; Read and Williams, 2018; Wang et al., 2018) in addition to the time necessary for the first clinical gains (Mitchell, 2006), which by the way are very modest, represent important disadvantages of most available antidepressants (Cipriani…”
BackgroundSasaki, K., Linh, T. N., Hirano, A., Tominaga, K., Nukaga, S., Nozaki, H., Arimura, T., & Isoda, H. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113508 · Cited by 14
The Influence of Selective Serotonin Reuptake Inhibitors on Lumbar Arthrodesis
Pirkle, S., Bhattacharjee, S., Dafrawy, M. H. E., Leucht, P., Shi, L. L., & Lee, M. J. (2020) · Clinical Spine Surgery A Spine Publication · doi:10.1097/bsd.0000000000001075 · Cited by 12
Panariello, F., Kasper, S. F., Zohar, J., Souery, D., Montgomery, S., Ferentinos, P. P., Rujescu, D., Mendlewicz, J., Ronchi, D. D., Serretti, A., et al. (2022) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2134588 · Cited by 14
Agomelatine, Ketamine and Vortioxetine Attenuate Energy Cell Metabolism—In Vitro Study
Ľupták, M., Fišar, Z., & Hroudová, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213824 · Cited by 15
Cohen, Z. D., Breunese, J., Markowitz, J. C., Weitz, E. S., Hollon, S. D., Browne, D. T., Rucci, P., Corda, C., Menchetti, M., Weissman, M. M., et al. (2024) · Psychological Medicine · doi:10.1017/s0033291724001788 · Cited by 13
“…accessed form of treatment (Cipriani et al., 2018), issues surrounding long-term use (Bet, Hugtenburg, Penninx, & Hoogendijk, 2013), side effects (Ferguson, 2001), and patients ’ preference for psychotherapy (McHugh, Whitton, Peckham, Welge, & Otto, 2013; van Schaik et al., 2004) highlight the…”
Bazedoxifene plus conjugated estrogen to treat menopausal depression—A pilot study
Kulkarni, J., Mu, E., Li, Q., Malicka, M., Gavrilidis, E., de Castella, A. R., & Gurvich, C. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103527 · Cited by 12
Bali, V., Holmes, H. M., Johnson, M. L., Chen, H., Fleming, M. L., & Aparasu, R. R. (2016) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1680 · Cited by 11
Wang, J., Jian, L., Ni, X., Nie, G., Zeng, Y., Cao, X., Li, X., & Wang, X. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/7420394 · Cited by 11
Rezaei, S. S., Mittlböck, M., Reichardt, B., & Wolzt, M. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5117 · Cited by 11
“Selective serotonin reuptake inhibitors (SSRIs) are widely used in the treatment of depression, especially among older people.(5,6) In addition to being present on nerve cells, serotonin receptors are also expressed on the surface of platelets, and by inhibiting the reuptake of the agonist, SSRIs prolong the action of…”
BackgroundEnvironmental Enrichment Induces Meningeal Niche Remodeling through TrkB-Mediated Signaling
Zorzin, S., Corsi, A., Ciarpella, F., Bottani, E., Dolci, S., Malpeli, G., Pino, A., Amenta, A., Fumagalli, G. F., Chiamulera, C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910657 · Cited by 11
Evaluation of Bleeding in Orthopedic Surgery With Perioperative Use of Serotonergic Antidepressants
Yang, S. H., & Seifert, C. F. (2022) · Annals of Pharmacotherapy · doi:10.1177/10600280221134108 · Cited by 11
Durable recovery from amblyopia with donepezil
Wu, C., Gaier, E. D., Nihalani, B. R., Whitecross, S., Hensch, T. K., & Hunter, D. G. (2023) · Scientific Reports · doi:10.1038/s41598-023-34891-5 · Cited by 14
Jeon, S., Lee, C., Liu, Q. F., Kim, G. W., Koo, B., & Pak, S. C. (2014) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-014-0077-2 · Cited by 13
“For example, selective serotonin reuptake inhibitors (SSRIs) frequently cause gastrointestinal problems, insomnia, headache, anxiety and sexual dysfunction although they are the most commonly prescribed antidepressants [9].”
BackgroundWeight gain with add‐on second‐generation antipsychotics in bipolar disorder: a naturalistic study
Najar, H., Joas, E., Kardell, M., Pålsson, E., & Landén, M. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12737 · Cited by 13
“Several drugs used to treat bipolar disorder have also been associated with weight gain such as antidepressants (12), mood stabilizers (13), and second-generation antipsychotics (SGAs) (13).”
BackgroundLomas, T. (2017) · Routledge eBooks · doi:10.4324/9781315106304-18 · Cited by 11
Gynecological Management of Premenstrual Symptoms
SHULMAN, L. P. (2010) · Current Pain and Headache Reports · doi:10.1007/s11916-010-0131-9 · Cited by 11
“Regardless of the benefit of SSRIs for symptomatic women, there is a high rate of discontinuation because of treatment-related adverse events including lethargy, sleep disorders, and loss of libido [ 28 ].”
BackgroundNolan, T. L., Geffert, L. M., Kolber, B. J., Madura, J. D., & Surratt, C. K. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500133b · Cited by 11
Shin, D., Lee, S., Yi, S., Yoon, S. H., Cho, J., Bahng, M. Y., Jang, I., & Yu, K. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s126861 · Cited by 12
“Because daily SSRI medication may cause priapism, loss of bone mineral density, QTc interval prolongation, reduced libido and erectile dysfunction, as well as the short-term adverse effects of excess yawning, nausea, sweating, fatigue, and diarrhea due to the serotonin subreceptor selectivity and interaction with othe…”
Clegg, A. J., Hill, J. E., Mullin, D. S., Harris, C., Smith, C. J., Lightbody, C. E., Dwan, K., Cooney, G. M., Mead, G. E., & Watkins, C. L. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004366.pub7 · Cited by 12
Studt, A., Gannon, M. K., Orzel, J. A., Vaughan, A., & Pearlman, A. M. (2021) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-210039 · Cited by 13
Majeed, U., Aftab, M. F., Baloch, D. M., Ahmed, S., Yusuf, I. M., Hasan, M. A., & Qureshi, M. S. (2021) · Journal of Religion and Health · doi:10.1007/s10943-021-01431-2 · Cited by 13
“Conventional treatment for distress includes anti-depressants and selective serotonin re-uptake inhibitors (Ferguson, 2001); however, they pose risk of dependency and may add to the cost of therapy.”
BackgroundGilbert, J. B., Hieronymus, F., Eriksson, E., & Domingue, B. W. (2024) · Epidemiologic Methods · doi:10.1515/em-2024-0006 · Cited by 15
Bacteria Engineered to Produce Serotonin Modulate Host Intestinal Physiology
Mavros, C. F., Bongers, M., Neergaard, F. B. F., Cusimano, F. A., Sun, Y., Kaufman, A., Richardson, M., Kammler, S., Kristensen, M., Sommer, M. O. A., et al. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00453 · Cited by 11
Gualtieri, G., Cuomo, A., Pardossi, S., & Fagiolini, A. M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113858 · Cited by 11
“Although rare, cases have been reported even with monotherapy, as well as in combination with other serotonergic drugs such as MAOIs or triptans (Edinoff et al., 2021) [33,34].”
InfluentialMurthy, M. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.009 · Cited by 13
Huang, S., Galaj, E., Wang, J., Guo, Y., Wang, S., Shi, M., Yin, X., Liu, K., Luo, Y., Meng, L., et al. (2022) · Brain and Behavior · doi:10.1002/brb3.2833 · Cited by 10
“Available tricyclic medications and selective serotonin inhibitors for depression have a slowonset and can causemany unpleasant side effects including nausea, weight gain, sleep problems, and sexual dysfunction (Ferguson, 2001).”
BackgroundAkbarzadeh, F., Eslamzadeh, M., Behravan, G., Ebrahimi, A., Emami, S. A., Gilan, A., & Hoseinian, N. S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1105828 · Cited by 14
Safety of treatment for gastroparesis
Sarosiek, I., Bashashati, M., & McCallum, R. W. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1173204 · Cited by 10
Antidepressant Medication Treatment and Risk of Death
Zivin, K., Kim, H. M., Yosef, M., Maust, D. T., Valenstein, M. M., Smith, E. G., & Davydow, D. S. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000545 · Cited by 10
“This is counter to prevailing evidence of the lower risk profiles associated with SSRI use.(19) However, those profiles may not be focused on mortality as an outcome.”
ResultJustice, J. N., Silverstein‐Metzler, M. G., Uberseder, B., Appt, S. E., Clarkson, T. B., Register, T. C., Kritchevsky, S. B., & Shively, C. A. (2017) · GeroScience · doi:10.1007/s11357-017-9999-1 · Cited by 11
“Sertraline use in humans has known side effects that could be related to functional and activity-related outcomes including fatigue, tiredness, and gastrointestinal effects (Meijer et al. 2002; Ferguson 2001).”
BackgroundA systematic review of pharmacologic treatment efficacy for depression in older patients with cancer
Rabin, E. E., Kim, M., Mozny, A., Cardoza, K., Bell, A., Zhai, L., Bommi, P. V., Lauing, K. L., King, A. L., Armstrong, T. S., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100449 · Cited by 16
Liebowitz, M. R., Croft, H. A., Kajdasz, D. K., Whalen, H., Gallipoli, S., Athanasiou, M., & Reed, C. R. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4075 · Cited by 10
The Serotonin Link between Alcohol Use and Affective Disorders.
Ketcherside, A., Matthews, I., & Filbey, F. M. (2013) · PubMed · Cited by 14
Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
Lee, J., & Chang, S. M. (2022) · Psychiatry Investigation · doi:10.30773/pi.2022.0209 · Cited by 11
Stem cell-derived brain organoids for controlled studies of transcranial neuromodulation
Kubanek, J., Wilson, M., Rabbitt, R. D., Armstrong, C. J., Farley, A. J., Ullah, H. M. A., & Shcheglovitov, A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18482 · Cited by 9
Dexmedetomidine in the Treatment of Depression: An Up-to-date Narrative Review
Al-Mahrouqi, T., Al‐Alawi, M., & Freire, R. C. R. (2023) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/17450179-v19-230823-2023-4 · Cited by 11
Mahajna, M., Fanne, R. A., Berkovitch, M., Tannous, E. E., Vinker, S., Green, I., & Matok, I. (2023) · Biomedicines · doi:10.3390/biomedicines11123245 · Cited by 10
“There are several classes of antidepressants with near equal clinical efficacies in the treatment of depression [5].”
BackgroundBastaki, K., Elanbari, M., Ghuloum, S., & Jithesh, P. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050406 · Cited by 9
“Even though SSRIs have better safety and tolerability profiles than some of the older antidepressants, long-term use can lead to significant side effects, including sleep disturbances, weight gain, and sexual dysfunction, among others [35].”
BackgroundMedical Treatment of Disorders of Ejaculation
Chen, T., Mulloy, E. A., & Eisenberg, M. L. (2022) · Urologic Clinics of North America · doi:10.1016/j.ucl.2021.12.001 · Cited by 12
Ajaman, M., Naserzadeh, R., & Ghorbanzadeh, B. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000600 · Cited by 10
“Furthermore, the effect of antidepressants on other receptor systems, including cholinergic, histaminic, adrenergic, and serotonin receptors, led to the development of significant side effects that limited their use in the clinic (Ferguson, 2001).”
BackgroundTranslational Informatics for Natural Products as Antidepressant Agents
Singla, R. K., Joon, S., Shen, L., & Shen, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.738838 · Cited by 10
Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
Borovčanin, M., Vesić, K., Balcıoğlu, Y. H., & Mijailović, N. R. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1052710 · Cited by 9
“Expected somatic side effects such as nausea and abdominal discomfort, diarrhea and vomiting, headache, insomnia, drowsiness, and dry mouth may also occur (69).”
BackgroundGewichtszunahme unter Psychopharmakotherapie
Himmerich, H., Schuld, A., & Pollmächer, T. (2005) · Max Planck Institute for Plasma Physics · Cited by 9
Trends in the consumption of antidepressant drugs in Lithuania in 2002-2004.
Kaduševičius, E., Mikučionytė, L., Mačiulaitis, R., Milvidaitė, I., & Sveikata, A. (2006) · PubMed · Cited by 9
Rapkin, A. J., McDonald, M., & Winer, S. A. (2007) · Women s Health · doi:10.2217/17455057.3.4.395 · Cited by 9
“5-times more likely than women using placebo to withdraw from a study due to side effects [26], especially sexual dysfunction and weight gain [27,28].”
BackgroundCrits-Christoph, P. F., Gallop, R., Diehl, C., Yin, S., & Gibbons, M. B. C. (2016) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-016-0746-1 · Cited by 9
“…effects for various psychotropic medications and placebo, review articles on specific side effects such as sexual dysfunction and effects on sleep) (Ferguson 2001; Gartlehner et al. 2011; Gitlin 2003; Pagel and Parnes 2001; Montejo et al. 2001; Schweitzer et al. 2009; Serritti and Chiesa 2011;…”
BackgroundSabetnejad, Z., Assarian, F., Omidi, A., & Najarzadegan, M. R. (2016) · Electronic physician · doi:10.19082/3156 · Cited by 9
“One of the most important reasons for discontinuing these drugs is sexual dysfunctional caused by these medications (16).”
BackgroundPatel, R., Agrawal, S. K., & Jain, N. S. (2021) · Alcohol · doi:10.1016/j.alcohol.2021.06.002 · Cited by 8
Metadata
- Authors
- Ferguson, J. M.
- Affiliations
- University of Utah (US)
- Corresponding author
- Ferguson, James M.
- ORCID
- Ferguson, James M.
- Venue
- The Primary Care Companion For CNS Disorders
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2001-02-01
- Volume
- 3
- Issue
- 1
- Pages
- 22-27
- ISSN
- 2155-7772 (ISSN-L)
- 2155-7780
- PMC
- PMC181155
- OpenAlex
- W2024985387
- Cited by
- 669
- References
- 23
- Citations by year
- 2026: 26 · 2025: 35 · 2024: 33 · 2023: 46 · 2022: 63 · 2021: 69 · 2020: 56 · 2019: 64 · 2018: 45 · 2017: 47 · 2016: 36 · 2015: 28 · 2014: 27 · 2013: 24 · 2012: 11
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Primary Care Companion For CNS Disorders (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- selective serotonin reuptake inhibitors, antidepressant side effects, sexual dysfunction, weight gain, sleep disorders, depression treatment, primary care management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.